Inactive Instrument

Highlights LogicBio Therapeutics, Inc.

Equities

LOGC

US54142F1021

Highlights

Unlock all the news: Be the first to know and act before the market!

CANbridge Pharmaceuticals Inc. Announces Update on Collaborations with the Umass Chan Medical School and with Logicbio Therapeutics	04/23/04	CI
AstraZeneca Unit Completes Acquisition of LogicBio Therapeutics	16/22/16	MT
Alexion Pharmaceuticals, Inc. completed the acquisition of LogicBio Therapeutics, Inc. from a group of shareholders.	15/22/15	CI
LogicBio Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/22/14	CI
Earnings Flash (LOGC) LOGICBIO THERAPEUTICS Posts Q3 Revenue $2.7M	14/22/14	MT
Earnings Flash (LOGC) LOGICBIO THERAPEUTICS Posts Q3 Loss $-0.18	14/22/14	MT
LogicBio Therapeutics, Inc. and CANbridge Care Pharma Hong Kong Limited Enter into the Amended and Restated Exclusive Research Collaboration, License and Option Agreement	08/22/08	CI
AstraZeneca Unit To Buy US Biotech LogicBio Therapeutics	04/22/04	MT
AstraZeneca Unit to Acquire LogicBio Therapeutics; LogicBio Shares Soar	03/22/03	MT
LogicBio Therapeutics Shares Soar on Takeover by AstraZeneca	03/22/03	DJ
AstraZeneca pays 660% premium for gene therapy firm LogicBio	03/22/03	RE
Top Premarket Gainers	03/22/03	MT
AstraZeneca to Buy LogicBio Therapeutics for $68 Million	03/22/03	DJ
AstraZeneca Unit to Acquire LogicBio Therapeutics; LogicBio Shares Soar	03/22/03	MT
Alexion Pharmaceuticals, Inc. entered into a definitive agreement to acquire LogicBio Therapeutics, Inc. from a group of shareholders for $68.2 million.	03/22/03	CI
LogicBio Therapeutics, Inc Announces Pre-Clinical Results for mLB-001 Published in Peer-reviewed Journal PLOS ONE	21/22/21	CI
LogicBio Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	15/22/15	CI
Earnings Flash (LOGC) LOGICBIO THERAPEUTICS Reports Q2 Revenue $3.2M	15/22/15	MT
Earnings Flash (LOGC) LOGICBIO THERAPEUTICS Reports Q2 Loss $-0.15	15/22/15	MT
Exothera Announces Industrial Scale AAV Manufacturing Collaboration with LogicBio Therapeutics and Polyplus	15/22/15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights LogicBio Therapeutics, Inc.

Equities

LOGC

US54142F1021

Highlights

Filters